Related by context. Frequent words. (Click for all words.) 59 estrogen receptor ER 59 plus prednisone 56 metastatic renal cell carcinoma 56 sustained virologic response 55 axitinib 54 decitabine 54 pazopanib 54 temsirolimus 53 median PFS 53 neoadjuvant chemotherapy 53 ASA# 52 EORTC 52 HGS ETR1 52 vicriviroc 52 sapacitabine 52 HER2 negative 52 Phase IIa trial 52 gefitinib 51 ZYBRESTAT 51 xenograft models 51 HERmark 51 PXD# 51 Xyotax 51 free survival PFS 51 castration resistant prostate cancer 51 phase IIa 51 FOLFOX 51 virologic failure 51 bortezomib 51 GVAX 51 FDG PET 51 maribavir 51 NSCLC 50 liver metastases 50 HuMax CD# 50 tumor shrinkage 50 cytogenetic response 50 PCA3 50 evaluable 50 chemoradiation 50 histologic 50 Secondary endpoints 50 tumor recurrence 50 Phase 2b clinical 49 IIa clinical trial 49 ocrelizumab 49 Phase 2b study 49 FOLFIRI 49 distant metastases 49 phase 2a 49 relapsed multiple myeloma 49 randomized Phase III 49 BCX# 49 refractory Hodgkin lymphoma 49 tesmilifene 49 Phase 2a clinical 49 estrogen receptor negative 49 metastatic prostate cancer 49 Secondary endpoints include 48 HRPC 48 Secondary endpoints included 48 Phase 2a trial 48 RECIST criteria 48 Lp PLA2 48 Marqibo 48 zoledronic acid 48 poorer prognosis 48 Median survival 48 VIDAZA 48 EGFR inhibitors 48 elagolix 48 genotypic 48 RTOG 48 dose cohorts 48 pemetrexed 48 FOLOTYN 48 SBRT 48 Phase 2b trial 48 Phase IIa clinical 48 PCa 48 belinostat 48 risk stratification 48 topotecan 48 imatinib 47 ProLindac 47 SPIRIT III 47 estrogen receptor positive 47 bone metastasis 47 adjuvant chemotherapy 47 KRAS 47 TroVax 47 blinatumomab 47 ipilimumab 47 biomarker 47 HER2 positive 47 panitumumab 47 rNAPc2 47 denufosol 47 Phase IIb clinical 47 TELCYTA 47 multicenter clinical